| Ticker | Name | Performance (YTD) | Price | Return on Equity vs Industry | P/E | Forward P/E | P/S | P/B | P/Free Cash Flow | Dividend Yield | Float Short | Industry |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OGN | Organon & Co. | 5.16 | 15.69 | 238.40 | 4.71 | 3.74 | 0.63 | 8.20 | 5.41 | 7.35 | 6.46 | Drug Manufacturers - General |
| NVO | Novo Nordisk A/S ADR | -2.65 | 83.74 | 44.90 | 25.51 | 17.74 | 6.70 | 18.66 | 26.34 | 2.28 | 0.40 | Drug Manufacturers - General |
| SNY | Sanofi-Aventis S.A. ADR | 12.23 | 54.13 | -21.80 | 22.61 | 11.27 | 3.05 | 1.69 | 17.06 | 4.00 | 0.19 | Drug Manufacturers - General |
| AMGN | Amgen Inc | 14.31 | 297.93 | 44.10 | 39.48 | 13.76 | 4.82 | 27.22 | 15.40 | 3.27 | 2.38 | Drug Manufacturers - General |
| AZN | Astrazeneca Plc ADR | 13.80 | 74.56 | -8.20 | 33.08 | 14.71 | 4.28 | 5.67 | 22.49 | 2.17 | 0.55 | Drug Manufacturers - General |
| GILD | Gilead Sciences Inc | 19.12 | 110.03 | -24.80 | 296.66 | 13.17 | 4.77 | 7.12 | 14.54 | 2.94 | 1.84 | Drug Manufacturers - General |
| ABBV | Abbvie Inc | 13.04 | 200.88 | 102.00 | 83.99 | 14.41 | 6.30 | 106.65 | 19.89 | 3.21 | 1.07 | Drug Manufacturers - General |
| GSK | Gsk Plc ADR | 9.28 | 36.96 | -7.50 | 23.36 | 7.95 | 1.88 | 4.40 | 12.46 | 4.38 | 0.85 | Drug Manufacturers - General |
| JNJ | Johnson & Johnson | 10.41 | 159.68 | -5.80 | 27.54 | 14.41 | 4.33 | 5.38 | 19.38 | 3.19 | 0.78 | Drug Manufacturers - General |
| LLY | Eli Lilly and Company | 13.10 | 873.12 | 33.30 | 74.51 | 29.88 | 18.40 | 58.26 | 592.13 | 0.81 | 0.80 | Drug Manufacturers - General |
| MRK | Merck & Company | -11.86 | 87.68 | 1.80 | 13.02 | 8.86 | 3.45 | 4.99 | 14.95 | 3.72 | 1.17 | Drug Manufacturers - General |
| NVS | Novartis Ag ADR | 10.28 | 107.31 | 1.60 | 18.27 | 12.55 | 4.21 | 4.81 | 13.04 | 3.63 | 0.21 | Drug Manufacturers - General |
| PFE | Pfizer Inc | -2.37 | 25.90 | -20.90 | 18.40 | 8.50 | 2.31 | 1.59 | 17.84 | 6.55 | 1.30 | Drug Manufacturers - General |
Investment involves risk. As a general rule, you should only trade in financial products that you are familiar with and understand the risk associated with them. The risk warning described in each financial product below is not exhaustive, you should carefully consider your investment experience, financial situation, investment objective, risk tolerance level and consult your independent financial adviser as to the suitability of your situation prior making any investment.
